[Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

about

[Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

Item

http://www.wikidata.org/entity/Q40238572

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

[Medicinal prophylaxis during ...... ren and adolescents : part 2].

@en

type

Item

label

[Medicinal prophylaxis during ...... ren and adolescents : part 2].

@en

prefLabel

[Medicinal prophylaxis during ...... ren and adolescents : part 2].

@en

P1476

[Medicinal prophylaxis during ...... dren and adolescents : part 2]

@en

P2093

F Speth

http://www.w3.org/2001/XMLSchema#string

N Wellinghausen

http://www.w3.org/2001/XMLSchema#string

P2860

Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Infectious diseases associated with complement deficiencies.

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

Splenic atrophy in systemic lupus erythematosus.

Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.

Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.

P2888

s00393-013-1203-0

P304

896-909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00393-013-1203-0

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johannes-peter Haas

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23929242

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

[Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

about

[Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921